Proteomics


Discovery of a novel mechanism unique to severe COVID leads to a potential treatment

In a large meta-analysis, circulating protein levels of severe COVID patients along with many thousands of genomic datasets leads to an exciting discovery: a mutation in a gene called FAS that turns it into a non-membrane-bound, soluble form, interrupting normal immune function. In addition, an on-market chemotherapeutic drug has been […]


The UK Biobank – a veritable fountain of discovery

With a robust collection of 500,000 individuals, the UK Biobank will succeed in its mission to study the determinants of disease through genetics and proteomics combined with extensive electronic health records and ongoing assessments What the UK Biobank is and its current status The UK Biobank (abbreviated UKB or UKBB) […]

Milestones of the UK Biobank

The next leap in Personalized Medicine will be advances in sensor technology like Cardea

Can a graphene biosensor company like Cardea Biosciences play a role in making P4 medicine (predictive, preventive, personalized and participatory medicine) a reality? Lee Hood’s vision for P4 medicine It was about six years ago I attended a Personalized Healthcare conference at Virginia Commonwealth University in Richmond Virginia, where Leroy […]

The Agile R100 handheld reader